DJIA 17,791.12 12.97 0.07%
NASDAQ 4,751.66 3.26 0.07%
S&P 500 2,068.88 7.65 0.37%
market minute promo

Genomic Health (NASDAQ: GHDX)

31.19 -0.25 (-0.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GHDX $31.19 -0.80%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $31.12
Previous Close $31.44
Daily Range $30.76 - $31.20
52-Week Range $23.90 - $37.75
Market Cap $989.4M
P/E Ratio -35.33
Dividend (Yield) $0.00 (0.0%)
Volume 50,083
Average Daily Volume 151,091
Current FY EPS -$0.79

Sector

Healthcare

Industry

Healthcare Information Services

Genomic Health (GHDX) Description

Genomic Health's diagnostic tests offer innovative cancer screening. Website: http://www.genomichealth.com/

News & Commentary Rss Feed

Genomic Health, Inc.'s Lumpy Growth

Revenue and test volume growth come back to earth, but investors should focus on the quarters ahead.

Genomic Health's Oncotype DX Positive in Multiple Studies - Analyst Blog

Genomic Health's Breast Cancer Test Yields Positive Results - Analyst Blog

Oncotype DX® DCIS Score™ Represents Breakthrough in Personalizing Treatment of Pre-Invasive Breast C

Oncotype DX® DCIS Score™ Represents Breakthrough in Personalizing Treatment of Pre-Invasive Breast Cancer

Genomic Health's Liquid Biopsy Tests Positive in Twin Studies - Analyst Blog

Short Interest Moves 14.7% Higher For GHDX

Genomic Health's Oncotype DX: Cancer Testing Made Easier - Analyst Blog

Genomic Health (GHDX) Downgraded From Hold to Sell

Oncotype DX Predicts Outcomes In Prostate Cancer Patients, Significantly Changes Treatment Recommend

Oncotype DX Predicts Outcomes In Prostate Cancer Patients, Significantly Changes Treatment Recommendations

Update: Genomic Health Q3 Earnings Suggest We're Still On Track

Genomic Health Q3 Loss Narrower than Expected, Revenues Lag - Analyst Blog

See More GHDX News...

GHDX's Top Competitors

GHDX $31.19 (-0.80%)
Current stock: GHDX
AMGN $169.00 (0.31%)
Current stock: AMGN
GILD $106.11 (0.54%)
Current stock: GILD
BIIB $358.10 (1.24%)
Current stock: BIIB